Office: (+45) 32 50 66 10
Fax: (+45)
32 52 18 48
Mail: dupharma(at)dupharma.dk
TECEOS®
| Isotope | Technetium (99mTc) |
| Number of radiolabelled preparations | 1 |
| Each
vial contains : 3,3-diphospho - 1,2 -propanedicarboxylic acid, tetrasodium salt (DPD) tin (II) - oxide N - (4 - aminobenzoyl) - L - glutamic acid, monosodium salt |
13.0 mg 0.23 mg 1.0 mg |
| Volume of pertechnetate 99mTc to use for reconstitution | 2 to 10 mL |
| Radiochemical purity | ≥ 95 % |
| Storage | 13 months, not above 25°C |
| Stability of labelled product | 8 h at 25°C |
| Activity per vial | 0.37 to 11.1 GBq |
| Indications / Posology | Bone scintigraphy 500
MBq (300 - 700 MBq) |
| Time between injection and examination | Late phase static
scintigraphy should be performed not earlier than 2 hours |
| Availability | From stock |